{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:15:31Z","timestamp":1790496931629,"version":"4.1.0"},"reference-count":40,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:00:00Z","timestamp":1431388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Human Gene Therapy Clinical Development"],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:p>\n                    Preclinical studies to assess biodistribution, safety, and initial efficacy of ART-I02, an adeno-associated type 5 (rAAV5) vector expressing human interferon \u03b2 (hIFN-\u03b2), were performed in a total of 24 rhesus monkeys with collagen-induced arthritis. All monkeys were na\u00efve or showed limited neutralizing antibody (Nab) titers to AAV5 at the start of the study. Animals were injected with a single intra-articular dose of ART-I02 or placebo, consisting of 3.2\u00d710\n                    <jats:sup>13<\/jats:sup>\n                    vg (Dose A=maximum feasible dose), 4.58\u00d710\n                    <jats:sup>12<\/jats:sup>\n                    vg (Dose B), or placebo in the first affected finger joint, the ipsilateral knee, and ankle joint at the same time point. Animals were monitored for clinical parameters and well-being with a maximum of 4 weeks, with the option that the severity of arthritis could necessitate an earlier time point of sacrifice. No adverse events were noted after injection of ART-I02. No abnormalities were observed after histological evaluation of all organs. At both dose levels, immunohistochemical staining indicated expression of hIFN-\u03b2. In animals injected with Dose A, we observed stabilization or a reduction in swelling in the finger joint in which vector was administered. The highest copy numbers of vector DNA were detected in synovial tissue of the injected joint and the draining lymph node of the injected knee. High titers of Nab to rAAV5 were observed at the end of the study. Five monkeys developed an rAAV5-specific T-cell response. Two monkeys developed Nab to hIFN-\u03b2. In conclusion, intra-articular injection of ART-I02 was well-tolerated and did not induce adverse events. After administration of Dose A of ART-I02, we observed a beneficial effect on joint swelling, substantiated by decreased histological inflammation and bone erosion scores. A GMP vector for clinical application has been manufactured and is currently being tested in GLP rodent studies, with the aim to move forward to a clinical trial.\n                  <\/jats:p>","DOI":"10.1089\/humc.2015.009","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T12:20:12Z","timestamp":1434630012000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":20,"title":["Safety, Biodistribution, and Efficacy of an AAV-5 Vector Encoding Human Interferon-Beta (ART-I02) Delivered via Intra-Articular Injection in Rhesus Monkeys with Collagen-Induced Arthritis"],"prefix":"10.1177","volume":"26","author":[{"given":"Lisette","family":"Bevaart","sequence":"first","affiliation":[{"name":"Arthrogen B.V., Amsterdam 1105 BA, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Aalbers","sequence":"additional","affiliation":[{"name":"Arthrogen B.V., Amsterdam 1105 BA, The Netherlands."},{"name":"Academic Medical Center\/University of Amsterdam","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel P.M.","family":"Vierboom","sequence":"additional","affiliation":[{"name":"Biomedical Primate Research Centre","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Broekstra","sequence":"additional","affiliation":[{"name":"Arthrogen B.V., Amsterdam 1105 BA, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanela","family":"Kondova","sequence":"additional","affiliation":[{"name":"Biomedical Primate Research Centre","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Breedveld","sequence":"additional","affiliation":[{"name":"Biomedical Primate Research Centre","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Hauck","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Fraser","family":"Wright","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Peter","family":"Tak","sequence":"additional","affiliation":[{"name":"Arthrogen B.V., Amsterdam 1105 BA, The Netherlands."},{"name":"Academic Medical Center\/University of Amsterdam","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margriet J.","family":"Vervoordeldonk","sequence":"additional","affiliation":[{"name":"Arthrogen B.V., Amsterdam 1105 BA, The Netherlands."},{"name":"Academic Medical Center\/University of Amsterdam","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2015,5,12]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri802"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01661"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel047"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.035063"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2005.16.426"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2009.182"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2012.55"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.2741\/1475"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/ar598","article-title":"Interferon-beta for treatment of rheumatoid arthritis?","volume":"4","author":"van Holten J","year":"2002","unstructured":"van Holten J, , Plater-Zyberk C, , Tak PP. Interferon-beta for treatment of rheumatoid arthritis?. Arthritis Res, 2002; 4:346\u2013352.","journal-title":"Arthritis Res"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.097899"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/1529-0131(200002)43:2<270::AID-ANR5>3.0.CO;2-H","article-title":"The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis","volume":"43","author":"Smeets TJ","year":"2000","unstructured":"Smeets TJ, , Dayer JM, , Kraan MC, et al. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis. Arthritis Rheum, 2000; 43:270\u2013274.","journal-title":"Arthritis Rheum"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/rheumatology\/38.4.362","article-title":"The effects of interferon beta treatment on arthritis","volume":"38","author":"Tak PP","year":"1999","unstructured":"Tak PP, , Hart BA, , Kraan MC, et al., The effects of interferon beta treatment on arthritis. Rheumatology (Oxford), 1999; 38:362\u2013369.","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/416744a"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/416686a"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/ard.61.12.1047","article-title":"Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis","volume":"61","author":"Crotti TN","year":"2002","unstructured":"Crotti TN, , Smith MD, , Weedon H, et al. Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis, 2002; 61:1047\u20131054.","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.06.013"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/molbev\/msi127","article-title":"Reduced MIC gene repertoire variation in West African chimpanzees as compared to humans","volume":"22","author":"de Groot NG","year":"2005","unstructured":"de Groot NG, , Garcia CA, , Verschoor EJ, et al. Reduced MIC gene repertoire variation in West African chimpanzees as compared to humans. Mol Biol Evol, 2005; 22:1375\u20131385.","journal-title":"Mol Biol Evol"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1165"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199901)42:1<90::AID-ANR12>3.0.CO;2-A"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.020347"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2006.17.985"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.1053"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.82603-0"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/rheumatology\/37.3.314","article-title":"Collagen-induced arthritis in rhesus monkeys: evaluation of markers for inflammation and joint degradation","volume":"37","author":"Hart BA","year":"1998","unstructured":"Hart BA, , Bank RA, , De Roos JA, et al. Collagen-induced arthritis in rhesus monkeys: evaluation of markers for inflammation and joint degradation. Br J Rheumatol, 1998; 37:314\u2013323.","journal-title":"Br J Rheumatol"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1073\/pnas.0409084102","article-title":"Unparalleled complexity of the MHC class I region in rhesus macaques","volume":"102","author":"Otting N","year":"2005","unstructured":"Otting N, , Heijmans CM, , Noort RC, et al. Unparalleled complexity of the MHC class I region in rhesus macaques. Proc Natl Acad Sci USA, 2005; 102:1626\u20131631.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2007.02.012"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1773"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.175.4.933","article-title":"Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region","volume":"175","author":"Bakker NP","year":"1992","unstructured":"Bakker NP, , van Erck MG, , Otting N, et al. Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region. J Exp Med, 1992; 175:933\u2013937.","journal-title":"J Exp Med"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01487.x"},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar4605","article-title":"Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice","volume":"16","author":"Lindh I","year":"2014","unstructured":"Lindh I, , Snir O, , Lonnblom E, et al. Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice. Arthritis Res Ther, 2014; 16:R143.","journal-title":"Arthritis Res Ther"},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/art.20850","article-title":"Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5","volume":"52","author":"Vierboom MP","year":"2005","unstructured":"Vierboom MP, , Zavodny PJ, , Chou CC, et al. Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5. Arthritis Rheum, 2005; 52:627\u2013636.","journal-title":"Arthritis Rheum"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.3.3.299"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2013.166"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2010.155"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-010181"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000659"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300680"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2005.02.021"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1358"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63016-7"}],"container-title":["Human Gene Therapy Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/humc.2015.009","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/humc.2015.009","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/humc.2015.009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:51:34Z","timestamp":1773247894000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/humc.2015.009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,12]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6,1]]}},"alternative-id":["10.1089\/humc.2015.009"],"URL":"https:\/\/doi.org\/10.1089\/humc.2015.009","relation":{},"ISSN":["2324-8637","2324-8645"],"issn-type":[{"value":"2324-8637","type":"print"},{"value":"2324-8645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,12]]}}}